Salpingo-oophoritis

Summary

Salpingo-oophoritis (MONDO:0001172) is a disease and 2 clinical trials. A subtype of salpingitis — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Clinical trials: 2

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	salpingo-oophoritis
Mondo ID	MONDO:0001172
DOID	DOID:10972
NCIT	C171201
SNOMED CT	46536000
UMLS	C0036133
MedGen	508106
Is cancer (heuristic)	no

Also known as: tubo ovarian abscess · tubo-ovarian abscess · tubo-ovarian abscess (disorder) · Tubo-ovarian inflammatory disease

Disease family

This is a subtype of salpingitis. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › reproductive system disorder › female reproductive system disorder › pelvic inflammatory disease › salpingitis › salpingo-oophoritis

Related subtypes (5): tuberculous salpingitis, acute salpingitis, chronic salpingitis, pyosalpinx, gonococcal salpingitis

Subtypes (2): acute salpingo-oophoritis, chronic salpingo-oophoritis

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 2.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	2

Top trials by phase / activity

NCT	Phase	Status	Title
NCT03166982	Not specified	UNKNOWN	Drainage of Tubo - Ovarian Abscess: DTOA
NCT04817631	Not specified	COMPLETED	Management of Tubo-ovarian Abscess: a Single Center Experience